Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Neil M Carleton

22PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

Sort by Publication Date:
|Mar 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Sep 02, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

|Jun 19, 2025
Reciprocal immune-epithelial interaction during breast cancer induction.

Neil Carleton, Michael T Lotze

|Jun 09, 2025
Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring.

Neil Carleton, Priscilla F McAuliffe

|Mar 03, 2025
CITEgeist: Cellular Indexing of Transcriptomes and Epitopes for Guided Exploration of Intrinsic Spatial Trends.

Alexander Chih-Chieh Chang, Brent T Schlegel, Neil Carleton

Pageof 4

Frequent Collaborators

12 joint publications

Adrian V Lee

10 joint publications

Steffi Oesterreich

3 joint publications

Zheqi Li

3 joint publications

Alexander Chih-Chieh Chang

3 joint publications

George Tseng

2 joint publications

Fangyuan Chen

2 joint publications

Emilia J Diego

2 joint publications

Julia Foldi

2 joint publications

Norman Wolmark

2 joint publications

Marija Balic

Frequent Collaborators

12 joint publications

Adrian V Lee

10 joint publications

Steffi Oesterreich

3 joint publications

Zheqi Li

3 joint publications

Alexander Chih-Chieh Chang

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.1K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
See more related videos